The Journal of heart and lung transplantation, 2006-06, Vol.25 (6), p.726-729
2006
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Sirolimus for Kaposi’s Sarcoma
- Ist Teil von
- The Journal of heart and lung transplantation, 2006-06, Vol.25 (6), p.726-729
- Ort / Verlag
- New York, NY: Elsevier Inc
- Erscheinungsjahr
- 2006
- Quelle
- Elsevier ScienceDirect Journals
- Beschreibungen/Notizen
- The risk of Kaposi’s sarcoma (KS) is increased after organ transplantation. Management of KS in the cardiac transplant population may be difficult because reduction of immunosuppression is often not practical. This report describes a case of KS occurring in the early post-transplant period. Modification of immunosuppression with the use of sirolimus led to tumor regression for 24 months, but with subsequent localized progression of disease.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1053-2498eISSN: 1557-3117DOI: 10.1016/j.healun.2006.01.010Titel-ID: cdi_proquest_miscellaneous_68015033
- Format
- –
- Schlagworte
- Adult, Antibacterial agents, Antibiotics. Antiinfectious agents. Antiparasitic agents, Biological and medical sciences, Dermatology, Heart Transplantation, Herpesvirus 8, Human, Humans, Immunocompromised Host, Immunosuppressive Agents - therapeutic use, Lung Neoplasms - drug therapy, Lung Neoplasms - pathology, Male, Medical sciences, Myocardial Ischemia - surgery, Pharmacology. Drug treatments, Postoperative Period, Sarcoma, Kaposi - diagnosis, Sarcoma, Kaposi - drug therapy, Sarcoma, Kaposi - pathology, Sirolimus - therapeutic use, Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases, Surgery of the heart, Tumors of the skin and soft tissue. Premalignant lesions